Nonnucleoside HIV-1 reverse transcriptase inhibitors; part 3. Synthesis and antiviral activity of 5-alkyl-2-[(aryl and alkyloxyl-carbonylmethyl)thio]-6-(1-naphthylmethyl) pyrimidin-4(3H)-ones. 2004

Yanping He, and Fener Chen, and Xiongjie Yu, and Yueping Wang, and Erik De Clercq, and Jan Balzarini, and Christophe Pannecouque
Department of Chemistry, Fudan University, Shanghai 200433, People's Republic of China.

A series of 6-naphthylmethyl substituted S-alkylated dihydroalkoxybenzyloxopyrimidine (S-DABO) analogues with a beta-carbonyl group on the C-2 side chain were synthesized. All of the new compounds were evaluated for their anti-HIV activities in MT-4 cells. The most active compound, 5-isopropyl-2-[(4'-methoxyphenylcarbonyl-methyl)thio]-6-(1-naphthylmethyl)pyrimidin-4(3H)-one showed activity against HIV-1 and against the double mutated strain of HIV(Y181C and K103N) in the micromolar range. Furthermore, some of the compounds are active against both HIV-1 and HIV-2 in cell culture. In view of the fact that the loss of antiviral activity of these compounds when tested against S0561945 was much less pronounced than the loss of activity of typical NNRTIs, it is concluded that some of the compounds might interfere with another target or act on reverse transcriptase in a different way than the typical NNRTIs.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D011744 Pyrimidinones Heterocyclic compounds known as 2-pyrimidones (or 2-hydroxypyrimidines) and 4-pyrimidones (or 4-hydroxypyrimidines) with the general formula C4H4N2O. Pyrimidinone,Pyrimidone,Pyrimidones
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015498 HIV-2 An HIV species related to HIV-1 but carrying different antigenic components and with differing nucleic acid composition. It shares serologic reactivity and sequence homology with the simian Lentivirus SIMIAN IMMUNODEFICIENCY VIRUS and infects only T4-lymphocytes expressing the CD4 phenotypic marker. HTLV-IV,Human T-Lymphotropic Virus Type IV,Human immunodeficiency virus 2,LAV-2,HIV-II,Human Immunodeficiency Virus Type 2,Human T Lymphotropic Virus Type IV,Immunodeficiency Virus Type 2, Human,SBL-6669

Related Publications

Yanping He, and Fener Chen, and Xiongjie Yu, and Yueping Wang, and Erik De Clercq, and Jan Balzarini, and Christophe Pannecouque
July 2003, Chemical & pharmaceutical bulletin,
Yanping He, and Fener Chen, and Xiongjie Yu, and Yueping Wang, and Erik De Clercq, and Jan Balzarini, and Christophe Pannecouque
April 2008, Bioorganic & medicinal chemistry,
Yanping He, and Fener Chen, and Xiongjie Yu, and Yueping Wang, and Erik De Clercq, and Jan Balzarini, and Christophe Pannecouque
March 2020, Acta pharmaceutica Sinica. B,
Yanping He, and Fener Chen, and Xiongjie Yu, and Yueping Wang, and Erik De Clercq, and Jan Balzarini, and Christophe Pannecouque
July 2011, Bioorganic & medicinal chemistry,
Yanping He, and Fener Chen, and Xiongjie Yu, and Yueping Wang, and Erik De Clercq, and Jan Balzarini, and Christophe Pannecouque
June 1998, Bioorganic & medicinal chemistry letters,
Yanping He, and Fener Chen, and Xiongjie Yu, and Yueping Wang, and Erik De Clercq, and Jan Balzarini, and Christophe Pannecouque
September 2016, Chemical biology & drug design,
Yanping He, and Fener Chen, and Xiongjie Yu, and Yueping Wang, and Erik De Clercq, and Jan Balzarini, and Christophe Pannecouque
August 2005, Chemical & pharmaceutical bulletin,
Yanping He, and Fener Chen, and Xiongjie Yu, and Yueping Wang, and Erik De Clercq, and Jan Balzarini, and Christophe Pannecouque
May 2011, ChemMedChem,
Yanping He, and Fener Chen, and Xiongjie Yu, and Yueping Wang, and Erik De Clercq, and Jan Balzarini, and Christophe Pannecouque
April 2007, Journal of medicinal chemistry,
Copied contents to your clipboard!